Sinus bradycardia causes: Difference between revisions

	Sinus bradycardia Microchapters
Home
Patient Information
Overview
Pathophysiology
Causes
Differentiating Sinus bradycardia from other Diseases
Epidemiology and Demographics
Risk Factors
Natural History, Complications and Prognosis
Diagnosis
History and Symptoms
Physical Examination
Laboratory Findings
Electrocardiogram
Treatment
Medical Therapy
Primary Prevention
Case Studies
Case #1
Sinus bradycardia causes On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Sinus bradycardia causes All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
Guidance
FDA on Sinus bradycardia causes
on Sinus bradycardia causes
Sinus bradycardia causes in the news
Blogs on Sinus bradycardia causes
Directions to Hospitals Treating Sinus bradycardia
Risk calculators and risk factors for Sinus bradycardia causes

← Older edit Newer edit →

VisualWikitext

Revision as of 18:42, 26 August 2013

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Ayokunle Olubaniyi, M.B,B.S [2]

Overview

Causes

Life Threatening Causes

Common Causes

Causes by Organ System

Cardiovascular	Carotid sinus hypersensitivity , endocarditis , hypertrophic cardiomyopathy, left ventricular noncompaction, LQT4 mutation, myocardial infarction, myocarditis, pericarditis, sick sinus syndrome, vasovagal syncope
Chemical/Poisoning	Carbamate poisoning, lily of the valley poisoning, nerve agent, organophosphates
Dental	No underlying causes
Dermatologic	No underlying causes
Drug Side Effect	Adenosine, alfentanil, ambenonium, amiodarone, atenolol, bethanechol, bupivacaine, calcium channel blocker, celecoxib, cilobradine,^[1] citalopram, clonidine, deserpidine, diltiazem, dimethyl sulfoxide, distigmine, dronedarone, febuxostat, fentanyl,fingolimod, flecainide, fosphenytoin, grayanotoxin, guanethidine, H2 receptor antagonist, ivabradine, lanreotide, lidocaine , lofexidine, mefloquine, methyldopa, mexiletine, muscarine, nadolol, nefazodone,neostigmine, paclitaxel , palonosetron, physostigmine , procainamide , propranolol , quinidine , rabeprazole, regadenoson, reserpine, sedative, somatostatin, sotalol, sufentanil,suxamethonium, toluene sniffing,topical cocaine, verapamil, veratridine (false hellebore), zaleplon, zatebradine ^[2]

|- |-bgcolor="LightSteelBlue" | Ear Nose Throat |bgcolor="Beige"| No underlying causes |- |-bgcolor="LightSteelBlue" | Endocrine |bgcolor="Beige"| No underlying causes |- |-bgcolor="LightSteelBlue" | Environmental |bgcolor="Beige"| No underlying causes |- |-bgcolor="LightSteelBlue" | Gastroenterologic |bgcolor="Beige"| No underlying causes |- |-bgcolor="LightSteelBlue" | Genetic |bgcolor="Beige"| No underlying causes |- |-bgcolor="LightSteelBlue" | Hematologic |bgcolor="Beige"| No underlying causes |- |-bgcolor="LightSteelBlue" | Iatrogenic |bgcolor="Beige"| No underlying causes |- |-bgcolor="LightSteelBlue" | Infectious Disease |bgcolor="Beige"| No underlying causes |- |-bgcolor="LightSteelBlue" | Musculoskeletal/Orthopedic |bgcolor="Beige"| No underlying causes |- |-bgcolor="LightSteelBlue" | Neurologic |bgcolor="Beige"| No underlying causes |- |-bgcolor="LightSteelBlue" | Nutritional/Metabolic |bgcolor="Beige"| No underlying causes |- |-bgcolor="LightSteelBlue" | Obstetric/Gynecologic |bgcolor="Beige"| No underlying causes |- |-bgcolor="LightSteelBlue" | Oncologic |bgcolor="Beige"| No underlying causes |- |-bgcolor="LightSteelBlue" | Ophthalmologic |bgcolor="Beige"| No underlying causes |- |-bgcolor="LightSteelBlue" | Overdose/Toxicity |bgcolor="Beige"| No underlying causes |- |-bgcolor="LightSteelBlue" | Psychiatric |bgcolor="Beige"| No underlying causes |- |-bgcolor="LightSteelBlue" | Pulmonary |bgcolor="Beige"| No underlying causes |- |-bgcolor="LightSteelBlue" | Renal/Electrolyte |bgcolor="Beige"| No underlying causes |- |-bgcolor="LightSteelBlue" | Rheumatology/Immunology/Allergy |bgcolor="Beige"| No underlying causes |- |-bgcolor="LightSteelBlue" | Sexual |bgcolor="Beige"| No underlying causes |- |-bgcolor="LightSteelBlue" | Trauma |bgcolor="Beige"| No underlying causes |- |-bgcolor="LightSteelBlue" | Urologic |bgcolor="Beige"| No underlying causes |- |-bgcolor="LightSteelBlue" | Miscellaneous |bgcolor="Beige"| No underlying causes |- |}

Causes in Alphabetical Order

References

↑ van bogaert, pp.; pittoors, f. (2003). "use-dependent blockade of cardiac pacemaker current (if) by cilobradine and zatebradine". eur j pharmacol. 478 (2–3): 161–71. PMID 14575801. Unknown parameter |month= ignored (help)
↑ ^2.0 ^2.1 ^2.2 Van Bogaert, PP.; Pittoors, F. (2003). "Use-dependent blockade of cardiac pacemaker current (If) by cilobradine and zatebradine". Eur J Pharmacol. 478 (2–3): 161–71. PMID 14575801. Unknown parameter |month= ignored (help)

Template:WikiDoc Sources

[van_bogaert-2003-1] van bogaert, pp.; pittoors, f. (2003). "use-dependent blockade of cardiac pacemaker current (if) by cilobradine and zatebradine". eur j pharmacol. 478 (2–3): 161–71. PMID 14575801. Unknown parameter |month= ignored (help)

[Van_Bogaert-2003-2] 2.0 ^2.1 ^2.2 Van Bogaert, PP.; Pittoors, F. (2003). "Use-dependent blockade of cardiac pacemaker current (If) by cilobradine and zatebradine". Eur J Pharmacol. 478 (2–3): 161–71. PMID 14575801. Unknown parameter |month= ignored (help)

[1]

[2]

@@ Line 18: / Line 18: @@
 |-
 |bgcolor="LightSteelBlue"| '''Chemical/Poisoning'''
-|bgcolor="Beige"| [[Carbamate poisoning]], [[lily of the valley poisoning]], [[nerve agent]], [[organophosphates]]
+|bgcolor="Beige"| [[Carbamate|Carbamate poisoning]], [[Lily of the Valley|lily of the valley poisoning]], [[nerve agent]], [[organophosphates]]
 |-
 |-bgcolor="LightSteelBlue"
@@ Line 31: / Line 30: @@
 |-bgcolor="LightSteelBlue"
 | '''Drug Side Effect'''
-|bgcolor="Beige"| No underlying causes
+|bgcolor="Beige"| [[Adenosine]], [[alfentanil]], [[ambenonium]], [[amiodarone]], [[atenolol]], [[bethanechol]], [[bupivacaine]], [[calcium channel blocker]], [[celecoxib]], [[cilobradine]],<ref name="van bogaert-2003">{{cite journal  | last1 = van bogaert | first1 = pp. | last2 = pittoors | first2 = f. | title = use-dependent blockade of cardiac pacemaker current (if) by cilobradine and zatebradine. | journal = eur j pharmacol | volume = 478 | issue = 2-3 | pages = 161-71 | month = oct | year = 2003 | doi =  | pmid = 14575801 }}</ref> [[citalopram]], [[clonidine]], [[deserpidine]], [[diltiazem]], [[dimethyl sulfoxide]], [[distigmine]], [[dronedarone]], [[febuxostat]], [[fentanyl]],[[fingolimod]], [[flecainide]], [[fosphenytoin]], [[grayanotoxin]], [[guanethidine]], [[H2 receptor antagonist]], [[ivabradine]], [[lanreotide]], [[lidocaine ]], [[lofexidine]], [[mefloquine]], [[methyldopa]], [[mexiletine]], [[muscarine]], [[nadolol]], [[nefazodone]],[[neostigmine]], [[paclitaxel ]], [[palonosetron]], [[physostigmine ]], [[procainamide  ]], [[propranolol ]], [[quinidine ]], [[rabeprazole]], [[regadenoson]], [[reserpine]], [[sedative]], [[somatostatin]], [[sotalol]], [[sufentanil]],[[suxamethonium]], [[toluene|toluene sniffing]],[[cocaine|topical cocaine]], [[verapamil]], [[veratridine|veratridine (false hellebore)]], [[zaleplon]], [[zatebradine]] <ref name="Van Bogaert-2003">{{Cite journal  | last1 = Van Bogaert | first1 = PP. | last2 = Pittoors | first2 = F. | title = Use-dependent blockade of cardiac pacemaker current (If) by cilobradine and zatebradine. | journal = Eur J Pharmacol | volume = 478 | issue = 2-3 | pages = 161-71 | month = Oct | year = 2003 | doi =  | PMID = 14575801 }}</ref>
+{{col-end}}
 |-
 |-bgcolor="LightSteelBlue"